Polymeric nanocarriers for drug delivery in osteosarcoma treatment
X Gu, J Ding, Z Zhang, Q Li, X Zhuang… - Current …, 2015 - ingentaconnect.com
Osteosarcoma (OS) is one of the most serious malignancies along with a high incidence in
children and teenagers. Although the neoadjuvant chemotherapy of OS has made great …
children and teenagers. Although the neoadjuvant chemotherapy of OS has made great …
[HTML][HTML] Recent advances of drug delivery nanocarriers in osteosarcoma treatment
SY Wang, HZ Hu, XC Qing, ZC Zhang… - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
Osteosarcoma is the most common primary malignant bone tumor mainly occurred in
children and adolescence, and chemotherapy is limited for the side effects and development …
children and adolescence, and chemotherapy is limited for the side effects and development …
[HTML][HTML] Drug delivery nanocarriers and recent advances ventured to improve therapeutic efficacy against osteosarcoma: an overview
SA Desai, A Manjappa, P Khulbe - Journal of the Egyptian National …, 2021 - Springer
Background Osteosarcoma (OS) is one of the key cancers affecting the bone tissues,
primarily occurred in children and adolescence. Recently, chemotherapy followed by …
primarily occurred in children and adolescence. Recently, chemotherapy followed by …
[HTML][HTML] Nanosized drug delivery strategies in osteosarcoma chemotherapy
Despite recent developments worldwide in the therapeutic care of osteosarcoma (OS), the
ongoing challenges in overcoming limitations and side effects of chemotherapy drugs …
ongoing challenges in overcoming limitations and side effects of chemotherapy drugs …
Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma-an updated review
Osteosarcoma could be a sort of threatening tumor that starts in a bone and spreads to
adjoining bone cells. Among the different sorts of bone malignancies, osteosarcoma is the …
adjoining bone cells. Among the different sorts of bone malignancies, osteosarcoma is the …
Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma
X Huang, W Wu, W Yang, X Qing, Z Shao - Colloids and Surfaces B …, 2020 - Elsevier
Osteosarcoma is one of the most common malignant bone tumors which affect adolescents.
Neoadjuvant chemotherapy followed by operation has become recommended for …
Neoadjuvant chemotherapy followed by operation has become recommended for …
Nanocarrier-based drug delivery systems for bone cancer therapy: a review
Bone cancer is a malignant tumor that originates in the bone and destroys the healthy bone
tissues. Of the various types of bone tumors, osteosarcoma is the most commonly diagnosed …
tissues. Of the various types of bone tumors, osteosarcoma is the most commonly diagnosed …
[HTML][HTML] Advanced nanoscale drug delivery systems for bone cancer therapy
Bone tumors are relatively rare, which are complex cancers and primarily involve the long
bones and pelvis. Bone cancer is mainly categorized into osteosarcoma (OS) …
bones and pelvis. Bone cancer is mainly categorized into osteosarcoma (OS) …
Research progress of nanomaterials in chemotherapy of osteosarcoma
T Yu, Z Cai, X Chang, C Xing, S White… - Orthopaedic …, 2023 - Wiley Online Library
Osteosarcoma (OS) is a common malignant bone tumor that occurs mostly in children and
adolescents. At present, surgery after chemotherapy or postoperative adjuvant …
adolescents. At present, surgery after chemotherapy or postoperative adjuvant …
[HTML][HTML] Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics
P Shi, Z Cheng, K Zhao, Y Chen, A Zhang… - Journal of …, 2023 - Springer
Osteosarcoma, the most common malignant tumor of the bone, seriously influences people's
lives and increases their economic burden. Conventional chemotherapy drugs achieve …
lives and increases their economic burden. Conventional chemotherapy drugs achieve …